TranS1 Announces Departure of CFO

Wilmington, N.C.-based TranS1, a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine, has announced that Michael Luetkemeyer, CFO, will leave the company on March 31, 2010 to pursue other opportunities, according to a TranS1 news release.

Advertisement

TranS1 has begun a search for his replacement, and Mr. Luetkemeyer will serve as a consultant to the company during the transition, according to the release.

Read the TranS1 release about Michael Luetkemeyer.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.